Download presentation
Presentation is loading. Please wait.
1
No conflicts of interest to declare.
Feasibility and Acceptability of Home-based HIV Testing Among Refugees: A Pilot Study in Nakivale Refugee Settlement in SW Uganda O’Laughlin KN, He W, Greenwald KE, Kasozi J, Chang Y, Mulogo E, Faustin ZM, Njogu P, Walensky RP, Bassett IV Kelli O’Laughlin, MD, MPH Massachusetts General Hospital Brigham and Women’s Hospital Harvard Medical School 26 July 2017 Thank you. We have no conflicts of interest. Supported by the Brigham and Women’s Department of Emergency Medicine, Harvard University Center for AIDS Research (NIH/NIAID 5P30AI060354), the Harvard Global Health Institute, the National Institute of Allergies and Infectious Diseases (R37 AI093269), and the National Institute of Mental Health (K23 MH and R01MH108427) No conflicts of interest to declare.
2
Background Refugees in Uganda risk exposure to HIV and many struggle to access HIV testing Nakivale Refugee Settlement in SW Uganda, est. 1960, 68,000 refugees Refugees are housed in zones by country of origin 4 health clinics in Nakivale serve refugees and nationals and provide free HIV testing and free ART In 2013, our routine clinic-based HIV testing study in Nakivale increased the mean HIV-positive clients identified per week from 0.9 to 5.6 (O’Laughlin et al, JAIDS 2014) Refugees in Uganda risk exposure to HIV and many struggle to access HIV testing Nakivale Refugee Settlement in SW Uganda, est. 1960, 68,000 refugees: 52% Democratic Republic of the Congo, 16% Somalia, 15% Burundi, 15% Rwanda, 2% Other; refugees are housed in zones by country of origin Four health clinics in Nakivale serve refugees and nationals and provide free HIV testing and free antiretroviral therapy In 2013, a routine clinic-based HIV testing intervention study our team conducted in Nakivale increased the mean HIV-positive clients identified/week from 0.9 to 5.6
3
Objectives Assess feasibility and acceptability of home-based testing Compare home and clinic-based HIV testing participants Methods Home-based HIV testing in Nakivale visiting homes up to 3 times (different days and times of day) in 3 distinct zones Feasibility: proportion of eligible participants at home Acceptability: proportion of those at home that tested Assessed effect of number of individuals at home and sex on willingness to test Compared age, gender, refugee status, distance to clinic, and HIV testing history of home and clinic-based testing participants Our first objective was to: “Assess the feasibility and acceptability of home-based HIV testing” in Nakivale Our second objective, was to compare characteristics of home-based and clinic-based testers To do this, We conducted home-based testing in Nakivale; visiting homes up to 3 times (different days/times) in 3 distinct geographic zones To evaluate feasibility, we assessed the proportion of eligible participants encountered at home To evaluate acceptability, we assessed the proportion of those at home that participated in HIV testing We also assessed the effect of the number of individuals at home as well as sex on willingness to test We compared age, gender, refugee status, distance to clinic, HIV testing history of home and clinic-based HIV testing participants [Note: gender and number of individuals at home and willingness to test--- evaluated with logistic regression models with general estimating equations (GEE) approach to account for clustering.] [Note 2: home-based and clinic-based testers compared using Wilxocon rank sum tests and Pearson’s chi-square tests]
4
Table 1. Feasibility and acceptability of home-based HIV testing,
of 319 households with 566 eligible individuals Variable At home, N (%) HIV tested, N (%) HIV +, N (%) Visit 1 353 (62%) 272 (77%) 6 (2.2%) Visit 2 127 (22%) 93 (72%) 1 (1.1%) Visit 3 27 (5%) 13 (44%) 0 (0%) Total 507 (90%) 378 (75%) 7 (1.9%) Table 2. Predictors of willingness to test Variable At home, N HIV tested, N (%) 1 person 99 73 (74%) 2 people 318 238 (75%) 3-5 people 77 67 (87%) Female 277 212 (77%) Male 217 166 (77%) For each additional person present, testing increased (OR 1.52, p=0.007) No difference in willingness to test by sex (p=0.66) Table 1- Demonstrates the Feasibility and acceptability of home-based HIV testing- of 319 households visited with 566 eligible individuals living in these households The column titled “At home” shows the number of eligible individuals encountered at home during visits 1-3 and in total. The next column titled “HIV tested” shows the number tested for HIV by visit, and the % tested of those at home during that visit. The final column shows the number found to be HIV+ in each visit. We found home-based testing to be FEASIBLE with 90% of eligible individuals encountered at home after 3 visits, and ACCEPTABLE with 75% of those at home willing to test for HIV. As noted in column 4, 7 participants were diagnosed as HIV+, and these were all found in the first 2 visits. Table 2. Titled “Predictors of willingness to test” The first column shows the variables 1 person, 2 people, 3-5 people present at time of the home visit; and then female and male. The second column shows the number present. The final column shows the number and % tested of those present. We found that for each additional person present, the odds of testing increased by 1.52 (OR 1.52, p=0.007). We found there was no difference in willingness to test by gender. (p=0.66)
5
Clinic-Based Testers*
Table 3. Characteristics of home-based and clinic-based HIV testing participants Variable* Home-Based Testers N=378 Clinic-Based Testers* N=6443 P-value Age, median (IQR) 30 (24-40) 28 (22-37) <0.001 Refugee 93% 79% ≥ 1 hour to clinic 74% 52% HIV-positive 1.9% 3.4% 0.27 Table 3. Titled “Characteristics of home-based and clinic-based HIV testing participants” demonstrates differences among home-based testers in column two and clinic-based testers in column three, using data gathered during our routine clinic-based HIV testing intervention study at Nakivale Health Center. Looking at Row 1, median age, home-based testers were older than clinic-based testers with a median age of 30 compared to 28. Row 2 shows Home-based testers were more often refugees, with the proportion refugees 93% compared to 79%. Row 3 demonstrates home-based testers were more likely to live greater than or equal to 1 hour from clinic, 74% home-based testers reported this compared to 52% clinic-based testers. The final row shows the HIV prevalence among those tested which was 1.9% for home-based testers and 3.4% for clinic-based testers, HIV prevalence was NOT statistically different between the two groups. Additional covariates assessed but found to not have statistically significant differences were gender and previous HIV test. *Sex and previous HIV test were assessed but were not statistically significant * O’Laughlin et al, JAIDS 2014
6
Conclusions: Home-based HIV testing in Nakivale
Feasible with 90% eligible encountered in 3 visits Acceptable with 75% of those at home tested for HIV Individuals were more willing to test with others home Reached a larger proportion of refugees and those living further from clinic compared to clinic-based testing Implications Home-based testing visits in refugee settlements should occur during times when multiple people will be home Given limited resources 2 home visits may be sufficient Will need to assess linkage to care for home-based testers as distance to clinic in this setting may impact linkage To conclude, our home-based HIV testing study in Nakivale Conclusions Home-based HIV testing in Nakivale Refugee Settlement was feasible with 90% eligible encountered in 3 visits Home-based HIV testing in Nakivale was acceptable with 75% of those home participating in testing Individuals were more willing to test with others home Home-based testing reached a larger proportion of refugees and those living further from clinic Implications Home-based testing visits in refugee settlements should occur during times when multiple people will be home Will need to assess linkage to care for home-based testers as distance to clinic in this setting may impact linkage
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.